News/Event

News

10 Feb. 2023

Heartseed announces first patient dosed in a phase 1/2 LAPiS Study with HS-001 - a cell therapy designed to restore heart function in people with advanced heart failure
HS-001 is manufactured by Nikon CeLL innovation.

14 Apr. 2020

Announcement of obtaining a license for manufacturing regenerative medicine products by Nikon CeLL innovation Co., Ltd.

1^st Mar. 2017

Web Renewal

7^th May 2015

Establish Nikon CeLL innovation Co., Ltd.

Event

12-14 Mar. 2020

The 19^th Congress of the Japanese Society for Regenerative Medicine (PACIFICO Yokohama)

26-28 Feb. 2020

6^th Regenerative Medicine Expo OSAKA (INTEX Osaka)

9-11 Oct. 2019

BioJapan 2019 (PACIFICO Yokohama)

21-23 Mar. 2019

The 18^th Congress of the Japanese Society for Regenerative Medicine (Kobe)

20-22 Feb. 2019

Medical Japan2019 (INTEX Osaka)

10-12 Oct. 2018

BioJapan 2018 (PACIFICO Yokohama)

21-23 Mar. 2018

The 17^th Congress of the Japanese Society for Regenerative Medicine (PACIFICO Yokohama)

21-23 Feb. 2018

Medical Japan2018 (INTEX Osaka)

27-29 Oct. 2017

8^th Asian Cellular Therrapy Organization, ACTO (St. Luke’s Center for Clinical Academia)

11-13 Oct. 2017

BioJapan 2017 (PACIFICO Yokohama)

28-30 Jun. 2017

21^st Annual Meeting of Japanese Association of Cancer Immunology (Makuhari Messe)

7-9 Mar. 2017

The 16^th Congress of the Japanese Society for Regeneratice Medicine (Sendai International Center)

15-17 Feb. 2017

Medical Japan2017 (INTEX Osaka)

12-14 Oct. 2016

BioJapan 2016 (PACIFICO Yokohama)

14-16 Oct. 2015

BioJapan 2016 (PACIFICO Yokohama)